AFHI11 — Reanálise Mai/2026: PVP em desconto, DPS R$ 1,03
Intermediate

AFHI11 — PVP Turned Discount, DPS Recovered to R$ 1,03 and Note Up to 7,7

Post-RG review Apr/2026: VP marked the market reverses historical agio and opens entry window with patrimonial protection.

Quotation (22/05) R$ 96,42 Liquidity R$ 730 thousand/day
VP/unit (MtM 15/May) R$ 97,11 was R$ 95,48 (30/abr)
May DPS R$ 1,03 vs R$ 0,97 (fev-abr)
DY 12m 12,47% CDI gross-up 114,5%
The turn of May/2026: 1,5% agio for 0,7% discount. O AFHI11 started to negotiate below equity for the first time in months, opening an entry window with real heritage protection — not just flow technique.

What has changed since the last analysis

The re-analysis of AFHI11 in May/2026 captures a simultaneous reconfiguration of four variables that together justify the upgrade of 7,6 for 7,7. . It is not an isolated catalyst, but a convergence: the market marking of CRIs in 15/May increased the VP/unit of R$ 95,48 for R$ 97,11 — a pure patrimonial movement without capture or amortisation. With the unit negotiated the R$ 96,42, the PVP left 1,5% Agio for 0,7% Discount, reversing the award that supported the thesis against the fund since February.

The second axis is the dividend. After three months anchored in R$ 0,97 (fev, mar and abr), the announcement of R$ 1,03 at 15/May (paid 22/May) interrupted the valley and returned the bottom to the January level. The movement is not cosmetic: the result by unit of April was R$ 1,1033, that is, the bottom generated box above the distributed dividend and is building mattress — today in R$ 0,30/cumulated unit of undistributed result.

The third vector is active recycling: the fund manager rotated the CRI Bem Brasil to higher rate, raising the average IPCA+ portfolio of IPCA+9,51% for IPCA+9,83% (+32 bps). And the fourth is the prepayment of CRI Socicam, who injected R$ 0,04/unit of extraordinary result in the month.

Result per unit: R$ 1,1033 — mattress imports

The detail that many analysts ignore in multi-category CRI funds is the relationship between result and dividing. . The AFHI11 distributed R$ 1,03 in May, but generated R$ 1,1033 in April — a break from 7,1% on distribution. . This slack was not consumed: it remained in the cashier, adding to the previous months. The current mattress of R$ 0,30/unit represents about 29% of a monthly dividend, which gives margin to soften specific shocks of the IPCA+ portfolio.

Why is that relevant? In October/2025, when the accumulated IPCA of August/25 came deflated, the fund distributed only R$ 0,85/unit — a drop of 18% over the normal level. At that moment, the mattress was lower and the bottom needed to pass the shock to the unit holder. Today, with R$ 0,30/unit saved, a similar event could be partially absorbed by management, preventing inflation volatility from linearly translating into dividend volatility.

Active management: recycling CRI Bem Brasil and prepayment Socicam

AF Invest Real Estate — fund manager linked to Ecosystem Araújo Sources (36 years of market, CVM in 20.475) — carried out in April/May two movements that deserve to be highlighted. The first was the sale of the CRI Bem Brasil in secondary market with later more profitable transaction buyback, raising the average rate of the IPCA+ portfolio in 32 basis points. . For a portfolio of R$ 457 million with 69% in IPCA+, this incremental spread represents relevant additional revenue over the coming months.

The second was the full prepayment of CRI Socicam, which released immediate cash and generated R$ 0,04/unit of extraordinary result In April. This type of non-recurrent operation is often underestimated: it demonstrates that management actively monitors exit opportunities and is not limited to carrying papers to maturity.

There are also two historical data that reinforce the history of execution: the IRR carried out in secondary operations was 18,23% on CRI Rochaverá and 24,62% on CRI Yoshii — returns compatible with high-yield profile, but with zero historical default. The fee structure is also favorable to the unit holder: 1,00% a.a. total, without performance, with emission costs fully borne by the fund manager.

The 8th issue: risk or opportunity?

The counterweight to the purchase thesis is the 8th issue in progress. . The right of preference (DP) opened on B3 in 20/May and closes 01/jun, with financial settlement in 18/jun. . The issue price is R$ 95,48/unit — exactly the 30/abr closure rate/PV before rescheduling. The pipeline released is from 12 CRIs totaling R$ 120 million.

Metric 7th Issue 8th Issue
Target capture ~R$ 80 Mi Up to R$ 80,07 Mi (+25% additional)
Capture performed ~R$ 22 Mi (27% from target) In progress
Price/unit VP of the season R$ 95,48 (= PV 30/abr)
Pipeline 12 CRIs / ZQX0ZX Mi
Preferential factor 0,17511 (every 100 units → 17 new)

The 7th issue captured only 27% from the target — a sign that the market's appetite for new fund shares is limited. On the one hand, this reduces the risk of aggressive dilution: probably the 8th will also be partial. On the other hand, it keeps the uptake cycle open, with recurrent technical pressure on the unit.

The detail that changes the game is the Current balance sheet discount. . Who buys today R$ 96,42 is paying 0,7% below of VP marked to market of 15/May. Those exercising the right of preference will pay R$ 95,48 — below the current VP and below the market quote. In other words: the existing unit that exercises DP captures the double discount (emission price vs VP + emission price vs market), while the new investor, without DP, still buys with small equity discount.

Warning: the 8th issue is restricted to Professional Investors. . Quotats average person can only participate via right of preference between 20/May and 01/jun. Anyone who does not exercise will have proportional dilution. We cover operational details in AFHI11 opens 8th emission of R$ 80 mi five months after the 7th capture only ZQX2ZX mi.

Risks of the IPCA+ model and volatility of the % CDI

Not every given deserves a celebration. AFHI11 loads 69,02% portfolio in IPCA+ CRIs — an exposure that has historically given prizes in inflationary cycles, but which penalises the unitholder in months of accelerated deflation or deflation. Data from the last 12 months illustrate volatility:

  • April/2025: ICD 130,8% (peak — high IPCA + favourable loading)
  • October/2025: R$ 0,85/unit distributed ( Aug/25 deflation reduced pass-through)
  • November/2025: CDI 96,8% (worst period reading)
  • May/2026: CDI gross-up 114,5% (partial recovery)

The magnitude between the CDI's 96,8% and 130,8% in just 12 months is considerable — and the investor who evaluates the fund only by the 12,47% 12m needs to understand that this number is the medium of good and bad months. In months of negative IPCA, the transfer to the unit holders may be dramatically smaller.

The second risk, contained today, is the exposure GPA of 1,02% portfolio. . The group is in extrajudicial recovery, but the CRIs of the AFHI11 have real guarantees — which limits potential loss. This is a mitigated risk, not eliminated.

Wallet: 69 CRIs, 13 segments, zero default

The AFHI11 portfolio follows an aggressive spray model: 69 CRIs distributed in 13 economic segments, with the largest debtor representing only 4,54% (Attack). The concentration top-4 — Wholesale (4,54%), Assai (4,53%), MRV (4,37%) and Muffato (4,25%) — sum 17,69%, which keeps the idiosyncratic risk under control.

By indexer, the allocation is:

  • IPCA+: 69,02% (average rate IPCA+9,83% after recycling)
  • CDI+: 29,51%
  • Preset: 1,45%

The historical highlight remains the zero default — no default operation registered since the constitution. The fund operates today with 38.622 unit holders and 4.789.190 units, keeping daily liquidity close to R$ 730 thousand in mobile window of 6 months.

Bucket Comparative: position 2 behind KNCR11

In the bucket Role · General · medium risk, the AFHI11 occupies today the position 2, with note 7,7 (COMPRA), behind only the KNCR11 (Note 8,6). . The difference is not trivial: KNCR11 delivers a less volatile bid (pure CDI+ without IPCA+), greater liquidity and Kinea management with consolidated track record. The AFHI11, on the other hand, offers higher IPCA+ prize and more aggressive active management in CRI recycling.

For investors who already have CDI+ exposure via KNCR11 or similar, AFHI11 works as a portfolio complement: adds the IPCA+ component with portfolio quality and management. For allocators in search of diversification within the paper segment, the fund meets. For the investor who prioritizes monthly dividend stability, the main recommendation remains the KNCR11.

Verdict

7,7 COMPRA

The AFHI11 enters in May/26 with technical configuration favorable to the buyer: VP marked the R$ 97,11, unit the R$ 96,42 (descount of 0,7%), DPS recovered the R$ 1,03 and result by unit of R$ 1,1033 above the dividend. Management demonstrated execution with recycling CRI Bem Brasil (+32 bps) and prepayment Socicam. The counterweight is the 8th emission in progress, but the history of the 7th (27% of the target) suggests limited dilution. Position 2 of the Paper-General budget, behind only KNCR11.